Sodium-dependent phosphate transporter NaPi2b as a potential predictive marker for targeted therapy of ovarian cancer.

Nurgalieva, A K; Popov, V E; Skripova, V S; Bulatova, L F; Savenkova, D V; Vlasenkova, R A; Safina, S Z; Shakirova, E Zh; Filonenko, V V; Bogdanov, M V; Kiyamova, R G

Nurgalieva, A K; Popov, V E; Skripova, V S; Bulatova, L F; Savenkova, D V; Vlasenkova, R A; Safina, S Z; Shakirova, E Zh; Filonenko, V V; Bogdanov, M V; Kiyamova, R G.

Afiliação

Nurgalieva AK; Research Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation.
Popov VE; Research Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation.
Skripova VS; Research Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation.
Bulatova LF; Research Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation.
Savenkova DV; Research Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation.
Vlasenkova RA; Research Laboratory "Biomarker", Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation.
Safina SZ; Republican Clinical Oncological Dispensary, Kazan, 420029, Russian Federation.
Shakirova EZ; Republican Clinical Oncological Dispensary, Kazan, 420029, Russian Federation.
Filonenko VV; Department of Surgery, Obstetrics, and Gynecology, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, 420008, Russian Federation.
Bogdanov MV; Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, 03680, Ukraine.
Kiyamova RG; Department of Biochemistry and Molecular Biology, University of Texas-Houston, McGovern Medical School, Houston, TX, 77225, USA.

Biochem Biophys Rep ; 28: 101104, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34504954

Palavras-chave

Molecular marker; NaPi2b; Neoadjuvant therapy; Ovarian cancer; Predictive marker; SLC34A2

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Biochem Biophys Rep Ano de publicação: 2021 Tipo de documento: Article País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google